1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation
(
- Contribution to journal › Article
-
Mark
Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring
(
- Contribution to journal › Article
- 2015
-
Mark
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.
(
- Contribution to journal › Article
-
Mark
Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
(
- Contribution to journal › Article
-
Mark
Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines.
(
- Contribution to journal › Article
- 2012
-
Mark
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.
(
- Contribution to journal › Article
- 2011
-
Mark
Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Benchmarks for Cystic Fibrosis carrier screening: A European consensus document
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods
(
- Contribution to journal › Article
-
Mark
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding